Healthcare Stocks With The Best Value For February 2022

One of the largest and most complex industries, the healthcare industry consists of a wide array of companies selling medical products and services. The healthcare industry includes companies that sell drugs, medical devices, and insurance, as well as hospitals and healthcare providers. Some of the world's largest healthcare companies include UnitedHealth Group Inc. (UNH), Pfizer Inc. (PFE) and AbbVie Inc. (ABBV) exists. The healthcare industry has caught the attention of investors as some of these companies have received approvals for drugs to treat Covid-19 and have begun distributing vaccines. While some companies are rushing to develop their own Covid-19 drugs and get approval, others are supplying products to test and manage the treatment of the virus. Despite this, healthcare stocks represented by the exchange-traded fund (ETF), Health Care Select Sector SPDR ETF (XLV), underperformed in the broader market. Health stocks reported an overall return of 12%.

Healthcare Stocks With The Best Value

These are health stocks with the lowest 12-month P/E ratio. Because profits can be returned to shareholders in the form of dividends and buybacks, a low P/E ratio means you pay less for each dollar of profit produced.

	Price ($)	Market Cap ($B)	12-Month Trailing P/E Ratio
Bio-Rad Laboratories Inc. (BIO)	587,4	17,6	2,7
Sage Therapeutics Inc. (SAGE)	38,82	2,3	3,1
Organon & Co. (OGN)	31,82	8,1	5,3

Bio-Rad Laboratories Inc.: Bio-Rad Laboratories manufactures products and systems used to separate chemical and biological materials as well as analyze, purify and identify components. The company's products are used in life science research, chemistry and health. Sage Therapeutics Inc.: Sage Therapeutics focuses on treatments for brain disorders. Specifically, it manufactures treatments for central nervous system disorders, including schizophrenia and major depressive disorder. J.P. on January 11, 2022. At the Morgan Healthcare Conference, the company presented detailed research and clinical findings for its investigational drug Zuranolone. Sage said that Zuranolone showed rapid improvement in depressive symptoms. This included 40% to 60% improvement in health areas, including mental health, vitality, and social functioning. Organon & Co.: Organon is a pharmaceutical company focused on women's health as well as established medicines. It develops and manufactures medicines for reproductive health, dermatology, heart disease, allergies and other fields.